NCAM1 and Stroke: In our previous study, we showed that intrathecal injection of adenoviral vectors carrying vegf, gdnf, and ncam, or genetically-modified UCB-MC+Ad5-VEGF-GDNF-NCAM, 4 h after stroke modelling in rats, had a positive effect on the morpho-functional recovery of the post-ischemic brain [25].